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Serotonin 2A (5‑HT2A) 
receptor affects cell–matrix 
adhesion and the formation 
and maintenance of stress fibers 
in HEK293 cells
Joe Anand Kumar John Jayakumar1,2*, Mitradas. M. Panicker2,3 & Basudha Basu1,2,4*
5‑HT2A, a G‑protein coupled receptor, is widely expressed in the human body, including in the 
gastrointestinal tract,  platelets and the nervous system. It mediates various functions, for e.g. 
learning, memory, mood regulation, platelet aggregation and vasoconstriction, but its involvement in 
cell‑adhesion remains largely unknown. Here we report a novel role for 5‑HT2A in cell–matrix adhesion.
In HEK293 cells, which are loosely adherent, expression and stimulation of human or rat 5‑HT2A 
receptor by agonists such as serotonin or 2,5‑dimethoxy‑4‑iodoamphetamine (DOI) led to a significant 
increase in adhesion, while inhibition of 5‑HT2A by antipsychotics, such as risperidone, olanzapine or 
chlorpromazine prevented it. 5‑HT2A activation gave rise to stress fibers in these cells and was also 
required for their maintenance. Mechanistically, the 5‑HT2A‑mediated adhesion was mediated by 
downstream PKC and Rho signaling. Since 5‑HT2A is associated with many disorders such as dementia, 
depression and schizophrenia, its role in cell–matrix adhesion could have implications for neural 
circuits.
The serotonin receptor subtype, 5-HT2A, is a G protein-coupled receptor expressed in multiple regions of the body 
e.g. gastrointestinal tract, liver, smooth muscles and platelets. It is also expressed in many areas of the central 
nervous system, which include the cortex and  hippocampus1–3. It affects behaviour, mood, sleep, thermoregu-
lation and multiple physiological processes such as muscle contraction and platelet  aggregation4–6. One of the 
classical roles of 5-HT2A is in platelet-aggregation. Exposure of platelets to vascular injury causes them to release 
serotonin and aggregate due to activation of their 5-HT2A  receptor7–9. While implicated in platelet aggregation, 
which is a form of `cell–cell adhesion’, 5-HT2A is not reported to be involved in ‘cell–matrix adhesion’.
In this study, we demonstrate that either the rat or human 5-HT2A receptors, when stably expressed and acti-
vated by  agonists10–13 in HEK293 cells, caused increased adhesion of these cells to a variety of natural substrates. 
Conversely, 5-HT2A-dependent increase in adhesion was consistently disrupted by antagonists of this receptor, 
including clinically used antipsychotics. Our experiments were done in DMEM without serum, which was sup-
plemented with ligands, pathway blockers or activators as required.
Dissecting the contributions of a single receptor subtype is difficult in vivo and neural cell lines due to the 
many serotonin receptor subtypes and multiple receptor subtypes being co-expressed in the same cell. We have 
limited the contribution of other serotonin receptors in this cell-based system by expressing a single receptor 
subtype i.e. 5-HT2A in HEK293 cells. This has allowed us not only to establish that the 5-HT2A receptor can 
play a significant role in affecting cell-substrate adhesion but also allowed us to identify some of the signaling 
pathways involved.
While the rat and human 5-HT2A share more than 90% sequence  homology14, they exhibit differences in their 
functional selectivity, desensitization and  resensitization11,13,15. Earlier reports from our laboratory had shown 
differences in internalization of human and rat 5-HT2A when activated by serotonin for e.g. the human 5-HT2A 
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took ~ 6 h to recycle back to cell membrane, whereas the rat 5-HT2A could do so in just 3  h13,15. Similarly, human 
5-HT2A internalization required β-arrestin and GRK-2 but rat 5-HT2A did  not15,16. These differences could also 
be attributed to just a few amino acid differences in the sequences of the two  receptors15. Our results suggest that 
though there are differences in signaling between the rat and human receptors, these differences did not extend 
to cell–matrix adhesion, which was similar between the human and rat 5-HT2A expressed in HEK293 cells. Our 
current study adds to the functional similarities and differences between human and rat receptors and describes 
the use of a cellular model which should be of use in the study of human psychiatric disorders like schizophrenia, 
which are routinely studied using animal model systems.
Results
Activation of 5‑HT2A leads to adhesion of HEK293 cells to multiple substrates. While HEK293 
cells are loosely adherent, expression and stimulation of 5-HT2A leads to an increase in their adhesion to typically 
used matrices in tissue culture. Our results show that in the absence of 5-HT2A receptor or its stimulation low 
cell to matrix adhesion and activating the receptor with 10 μM serotonin increased this adhesion significantly. 
As expected, this increase in adhesion was only seen in the receptor-expressing cells and not in the parental 
untransfected HEK293 cells, which lack this receptor.
HEK293 cells exhibited poor adhesion to tissue culture (TC) plastic surfaces pre-treated with DMEM sup-
plemented with 10% fetal bovine serum (FBS) (henceforth referred to as serum  ECM17), with only 37 ± 6% of 
cells remaining attached after being subjected to mechanical disruption. Treatment of HEK293 cells with 10 μM 
serotonin also did not significantly affect adhesion and only 38 ± 6% of HEK293 cells adhered in the presence 
of serotonin. In the case of  Hu2AAB1 cells or  Rat2ASB1 cells i.e. HEK293 cells expressing human or rat 5-HT2A 
respectively, stimulation with 10 μM serotonin led to increased adhesion under similar conditions. We found 
85 ± 4% (p < 0.01) of  Hu2AAB1 and 87 ± 7% (p < 0.001) of  Rat2ASB1 cells were adherent in the presence of sero-
tonin, while 39 ± 10% and 11 ± 8% cells of the respective untreated cells, which served as controls, remained 
adherent (Fig. 1A). Other than the initial treatment of the tissue culture plastic with serum-containing media, 
all experiments were done in the absence of serum, since serotonin is known to be present in sera. We also did 
some experiments using dialyzed serum which has negligible serotonin and it did not cause adhesion in the 
5-HT2A receptor-expressing cells (data not shown). Earlier studies using  Hu2AAB1 cells and  Rat2ASB1  cells13,15 
had used serotonin at 10 μM concentration to activate 5-HT2A. A dose–response study of serotonin-mediated 
adhesion was carried out on  Hu2AAB1 cells with serotonin concentrations ranging from 1 nM to 100 μM. Increase 
in adhesion was observed from 10 nM of serotonin onwards (Supplementary Fig. S2A) and adhesion was seen 
to be most significant and saturating at 10 μM. We have, therefore, used this concentration as a standard in most 
of our experiments.
We next examined adhesion on plates pre-coated with fibronectin, a common ECM component and a ligand 
for several integrins. 5-HT2A-mediated adhesion was also observed on this substrate with 86 ± 7% (p < 0.01) of 
 Hu2AAB1 cells and 86 ± 7% (p < 0.001) of  Rat2ASB1 cells adherent at 10 µM serotonin compared to 42 ± 17% for 
untreated  Hu2AAB1 and 9 ± 2% for  Rat2ASB1, which served as controls. The adhesion of HEK293 cells on the 
plate pre-coated with fibronectin showed no significant difference on treatment with serotonin and 51 ± 5% of 
untreated HEK293 cells and 49 ± 13% of 10 μM serotonin-treated cells remained adherent (Fig. 1B). We used 
fibronectin pre-coated TC plastic for most of our subsequent experiments, unless otherwise mentioned, due to 
its natural occurrence and abundance in various tissues.
Increased adhesion was also seen on stimulation of 5-HT2A with agonists of 5-HT2A e.g. DOI and dopamine. 
In  Hu2AAB1 cells, treatment with 10 μM DOI, a synthetic ligand of 5-HT2A, caused a massive increase in adhesion 
with 99 ± 13% of the cells staying adherent compared to only 42 ± 13% of untreated cells (p < 0.01). Treatment 
with10 μM dopamine, a partial agonist of 5-HT2A, also caused a significant increase in the adhesion with 59 ± 6% 
of cells adherent compared to only 40 ± 7% of untreated cells (p < 0.05) (Fig. 1C). On the other hand, HEK293 
cells did not show any increase in the presence of DOI or dopamine (Supplementary Fig. S2B).
We also created a comprehensive dataset compiled from all the experiments done during the entire duration 
of the study which details the variability in cell-adherence with and without 10 μM serotonin treatment, and 
is available in Supplementary Fig. S2C,D. The respective datasets for each group were seen to follow a normal 
distribution as determined by Lilliefors goodness-of-fit test of composite normality at alpha level of 0.05. The 
result of such a large scale compilation, clearly showed that in the absence of 5-HT2A receptor activation there is 
lower adhesion, and stimulation of 5-HT2A receptor with 10 μM serotonin led to maximal increases in adhesion 
(Supplementary Fig. S2C,D). In this dataset, the individual data points in each group did not always belong to 
the same day, and their respective sample sizes also varied, so we determined the normality of the distribution, 
and its mean and standard deviation to demonstrate robust reproducibility and consistency in adhesion caused 
by 5-HT2A expression and activation.
5‑HT2A‑mediated adhesion is specific to natural substrates. Since 5-HT2A mediated adhesion was 
similar on both fibronectin-coated and serum-adsorbed ECM substrates, adhesion was also examined on a non-
natural and widely used matrix i.e. poly-d-ornithine used in tissue culture. The adhesion seen with this molecule 
as substrate is known to be primarily based on electrostatic  complementarity18, and not dependent on the bio-
logical interactions between focal adhesions and ECM components.
In previously examined substrates,  Hu2AAB1 or  Rat2ASB1 cells showed an increase in adhesion only when 
5-HT2A was activated by an agonist; but on the synthetic substrate poly-d-ornithine,  Hu2AAB1 and  Rat2ASB1 cells 
remained fully adherent in the absence of any ligand. On poly-d-ornithine, 100 ± 3% of  Hu2AAB1 and 107 ± 12% 
 Rat2ASB1 cells were adherent in the absence of serotonin compared to 90 ± 7% and 105 ± 5% in the presence of 
10 µM serotonin respectively (Fig. 2A). Similarly, HEK293 cells which lack the 5-HT2A receptor, showed poor 
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Figure 1.  Expression and activation of 5-HT2A leads to adhesion of HEK293 cells to multiple substrates. (A) 
Cell adhesion profile of HEK293 cells,  Hu2AAB1 and  Rat2ASB1 cells treated with 10 µM serotonin compared 
to untreated control on serum ECM substrate. (B) Cell adhesion profile of HEK293,  Hu2AAB1 and  Rat2ASB1 
cells treated with 10 µM 5-HT compared to untreated control on a fibronectin substrate. (C) Cell adhesion 
profile of  Hu2AAB1 cells on treatment with 10 µM DOI a 5-HT2A-specific agonist, and 10 µM dopamine (DA), 
a partial agonist compared to their respective untreated controls on a fibronectin substrate. Error bars represent 
SD values. The data represented by the gray bars are compared against the respective black bars by two tailed 
students t test; p value less than 0.05 is considered significant. The corresponding p value for the asterisks are 
**p < 0.01, ***p < 0.001, NS p > 0.05.
Figure 2.  5-HT2A-mediated adhesion is specific to natural substrates. (A) Cell adhesion profile of HEK293, 
 Hu2AAB1 and  Rat2ASB1 cells on poly-d-ornithine substrates with 10 µM 5-HT compared to untreated controls. 
(B) Cell attachment profile of  Hu2AAB1 and HEK293 cell suspensions with or without pre-treatment with10 µM 
RGD peptide compared to non pre-treated controls. Error bars represent SD values. The data represented by the 
gray bars are compared against the respective black bars by two tailed students t test; p value less than 0.05 is 
considered significant. The corresponding p value for the asterisks are **p < 0.01, NS p > 0.05.
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adhesion on all natural substrates irrespective of the presence of serotonin. On poly-d-ornithine however, they 
exhibited strong non-specific adhesion with 94 ± 4% untreated and 94 ± 1% of 10 μM serotonin-treated cells 
adhering (Fig. 2A). It appears that all three cell lines attach well on poly-d-ornithine which causes adhesion via 
electrostatic interactions, and the adhesion is independent of 5-HT2A activity. Hence, we conclude that 5-HT2A-
mediated adhesion is observed only on biologically relevant matrices and that 5-HT2A activity not essential for 
cell adhesion on a non-natural substrate like poly-d-ornithine.
As 5-HT2A-mediated adhesion was found to be relevant only to natural substrates, but not with an artificial 
substrate such as poly-d-ornithine, we examined the biological processes involved. Since integrins engage with 
the RGD motifs of various ECM proteins including fibronectin, interfering with integrin–fibronectin interactions 
using RGD peptides would be expected to decrease cell attachment. For investigating the role of integrins in the 
attachment processes in these cells, cell-attachment was assayed in the presence and absence of RGD peptides. 
Briefly, enzyme-free cell dissociation buffer was used to dislodge the cells and cell suspension was exposed to 
RGD peptides prior to plating onto fibronectin-coated wells. The number of cells attached over a period of time 
was determined using PrestoBlue dye. We found that a 60-min pre-treatment with 20 μM RGD peptide, reduced 
the attachment of  Hu2AAB1 to12 ± 6%, whereas in the absence of RGD peptide, 62 ± 11% of cells attached over 
a period of 60 min (p < 0.005). Similarly, only 6 ± 6% of HEK293 cells pre-treated with 20 μM RGD peptide 
attached, compared to 50 ± 9% of cells that attached in the absence of RGD peptides (Fig. 2B) (p < 0.005) showing 
an involvement of integrins in this process.
This phenomenon of 5-HT2A-mediated cell–matrix adhesion is distinct from any effects of serotonylation of 
 fibronectin19. To rule out contributions from this process, we examined adhesion in the presence of cystamine, 
an inhibitor of transglutaminase, which blocks serotonylation. We found that on a fibronectin matrix, cystamine 
had no significant effect on 5-HT2A-mediated adhesion (Supplementary Fig. S2E).
Antipsychotics cause decrease in 5‑HT2A‑mediated adhesion. Since stimulation of 5-HT2A by ago-
nists in  Hu2AAB1 and  Rat2ASB1 cells caused an increase in the adhesion, the effect of antagonists/inverse agonists 
of 5-HT2A, some of which are antipsychotic  drugs, was probed. One of the characteristics of antipsychotics, espe-
cially atypical ones like risperidone, is their high affinity for 5-HT2A. As expected, various antipsychotics blocked 
agonist-stimulated increase in 5-HT2A-mediated adhesion. The loss of adhesion seen on inhibition of 5-HT2A 
was applicable only to natural substrates and not to poly-d-ornithine.
Inhibition of 5-HT2A by risperidone prevented serotonin-mediated increase in adhesion of  Hu2AAB1 and 
 Rat2ASB1 cells on serum-ECM coated plates. On stimulation of 5-HT2A receptor with 10 μM 5-HT, 85 ± 4% 
of  Hu2AAB1 cells and 87 ± 7% of  Rat2ASB1 remained adherent; but when 10 μM risperidone was also present 
the adhesion decreased, with only 33 ± 11% (p < 0.01) of  Hu2AAB1 and 7 ± 7%  Rat2ASB1 (p < 0.0005) adherent 
respectively. But in the case of HEK293 cells, just like serotonin, risperidone was found not to affect adhesion 
and 38 ± 6% of 10 μM serotonin-treated cells remained adherent as compared to 34 ± 7% cells treated with both 
10 μM risperidone and 10 μM serotonin (Fig. 3A).
Since we observed that the increased adhesion seen with 10 μM serotonin was abolished by 10 μM risperi-
done, we examined the effect of decreasing doses of risperidone on adhesion mediated by a lower concentration 
of serotonin. A dose–response study on  Hu2AAB1 cells in the presence of 100 nM serotonin and varying con-
centrations of risperidone (1 nM, 10 nM and 100 nM) showed that while 100 nM serotonin caused high levels 
of adhesion with 77 ± 10% cells adherent, risperidone at 10 nM completely abolished it. This was indistinguish-
able from results obtained with 100 nM risperidone treatment i.e. 31 ± 14% (p < 0.01) and 26 ± 11% (p < 0.005) 
cells remaining adherent in the presence 10 nM and 100 nM risperidone. 1 nM risperidone did not cause any 
significant reduction and 74 ± 9% cells remained adherent (p > 0.05) (Fig. 3B). The doses of risperidone needed 
to block 5-HT2A-mediated adhesion were also in accordance with the known affinity of risperidone for the 
5-HT2A receptor.
Risperidone affected 5-HT2A-mediated adhesion, on plates pre-coated with fibronectin as well. While 10 μM 
serotonin significantly increased adhesion of  Hu2AAB1 cells and  Rat2ASB1 cells with 105 ± 7% and 93 ± 10% 
respectively becoming adherent, this decreased significantly in the presence of 10 μM risperidone with only 
27 ± 4% (p < 0.001) of  Hu2AAB1 and 22 ± 1% (p < 0.0005) of  Rat2ASB1 cells remaining adherent. However, on 
poly-d-ornithine, inhibition of the receptor had no effect, and treatment with risperidone did not result in any 
decrease in adhesion with 90 ± 7% of 10 µM serotonin-treated  Hu2AAB1 cells remaining adherent compared to 
93 ± 1% of cells when 10 μM risperidone was also present. Similarly,  Rat2ASB1 cells did not exhibit any decrease 
in adhesion on poly-d-ornithine substrates when the 5-HT2A antagonist was present. In the presence of 10 µM 
serotonin alone 105 ± 5% of cells was adherent and when 10 µM risperidone was also present a comparable 
106 ± 6% of cells was found to be adherent (Fig. 3C).
This observed loss of adhesion on inhibition of 5-HT2A by antipsychotics was also determined with other 
5-HT2A agonists besides serotonin. All the antipsychotics we tested blocked the increase in adhesion triggered 
by complete and partial agonists of the 5-HT2A. Risperidone abolished the increase in adhesion seen with acti-
vation of 5-HT2A by DOI, a specific agonist, and dopamine, a partial agonist. In  Hu2AAB1 cells, 10 µM DOI 
caused 99 ± 13% of cells to adhere as compared to 25 ± 9% of cells when 10 µM risperidone was also present 
(p < 0.005). Likewise, in the presence of the partial agonist dopamine at 10 µM, 59 ± 6% of cells were adherent 
which decreased to 32 ± 14% when 10 µM risperidone was also present (p < 0.05) (Fig. 3D). Loss of adhesion 
due to inhibition of 5-HT2A was also consistently seen with other antipsychotics such as olanzapine, an atypical 
antipsychotic, and chlorpromazine, a typical antipsychotic. In  Hu2AAB1 cells, 10 μM serotonin treatment resulted 
in 105 ± 7% cells being adherent, but when either 10 μM olanzapine or 10 μM chlorpromazine was also present 
in addition to serotonin, adhesion decreased significantly and only 57 ± 4% (p < 0.0005) and 47 ± 2% (p < 0.0005) 
cells remained adherent respectively. Similarly 93 ± 10% of  Rat2ASB1 cells were adherent with 10 μM serotonin 
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Figure 3.  Inhibition of 5-HT2A by antipsychotics leads to loss of adhesion. (A) Cell adhesion profile of HEK293 
cells,  Hu2AAB1 or  Rat2ASB1 cells treated with 10 µM risperidone and 10 µM 5-HT compared to 10 µM 5-HT 
treatment alone on serum ECM substrate. (B) Cell adhesion profile of  Hu2AAB1 cells treated with varying 
concentration of risperidone—1 nM, 10 nM or 100 nM, in the presence of 100 nM serotonin compared to 100 nM 
5-HT treatment alone on a serum ECM substrate. (C) Cell adhesion profile of HEK293,  Hu2AAB1 and  Rat2ASB1 
cells in the presence of 10 µM risperidone and 10 µM 5-HT compared to control cells treated only with 10 µM 
5-HT treatment on fibronectin or poly-d-ornithine substrates. (D) Cell adhesion profile of  Hu2AAB1 cells treated 
with 10 μM risperidone along with either 10 μM DOI or 10 μM dopamine (DA) compared to their respective 
controls without risperidone on a fibronectin substrate. (E) Cell adhesion profile of  Hu2AAB1 and  Rat2ASB1 cells 
with 10 μM olanzapine or 10 μM chlorpromazine and 10 µM 5-HT treatments compared to 10 µM 5-HT treatment 
alone, on fibronectin substrate. Error bars represent SD values. The data represented by the gray bars are compared 
against the respective black bars by two tailed students t test; p value less than 0.05 is considered significant. The 
corresponding p value for the asterisks are *p < 0.05, **p < 0.01, ***p < 0.001, NS p > 0.05.
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treatment, but the adhesion was significantly reduced when 10 μM olanzapine or 10 μM chlorpromazine was 
also present, with only 11 ± 1% (p < 0.0005) and 6 ± 3% (p < 0.005) cells remaining adherent (Fig. 3E).
Stress fibers are modulated by the activity of 5‑HT2A. Since cell-substrate adhesion is associated 
with stress fibers, their role was examined in 5-HT2A-mediated adhesion. Phalloidin Alexa 568, which binds to 
F-actin was used to detect stress fibers. Stress fibers were seen to be formed or disrupted based on 5-HT2A activ-
ity, in the cells examined. Stimulation of 5-HT2A was found to be essential for the formation and maintenance of 
stress fibers and conversely inhibition of 5-HT2A resulted in the disruption of stress fibers.
In untreated  Hu2AAB1 cells without 5-HT2A stimulation, stress fibers were absent and stimulation of 5-HT2A 
by 10 μM serotonin resulted in robust stress fiber formation. Conversely, inhibition of 5-HT2A by 10 μM ris-
peridone, resulted in the disruption of stress fibers; and the fibers remained disrupted even in the presence of 
10 μM serotonin (Fig. 4A). The phase contrast images of the Phalloidin stained cells are presented in Fig. 4B.
The area occupied by stress fibers in a cell increased with 5-HT2A stimulation and decreased with inhibi-
tion, a trend similar to adhesion. In untreated control conditions, 40 ± 10% of total area occupied by cells had 
stress fibers, but in cells treated with10 μM serotonin a significant increase with 89 ± 18% (p < 0.001) of cell 
area having stress fibers was observed. Treatment with 10 μM risperidone alone or in the presence of 10 μM 
serotonin reduced stress fiber formation with 44 ± 10% (p < 0.001) area with risperidone alone and 36 ± 12% 
(p < 0.001) on co-treatment with serotonin (Fig. 4C). However, it is important to note that although there was 
no significant difference in the total cell area between control and serotonin-treated groups, the area occupied 
by a cell is significantly reduced when treated with risperidone as the cell begins to lose adhesion and round up 
(Supplementary Fig. S3A,B).
Since, stimulation of 5-HT2A led to the formation of stress fibers and increased adhesion, the effect of disrup-
tion of stress fibers on adhesion was explored. Stress fibers were therefore disrupted using latrunculin A under 
conditions of 5-HT2A-mediated adhesion. In  Hu2AAB1 cells, treatment with 10 μM serotonin alone caused 
91 ± 11% of cells to remain adherent but when 10 μM latrunculin A was used to disrupt stress fibers, only 19 ± 1% 
(p < 0.001) of the cells remained adherent (Fig. 4D).
PKC and Rho GTPase are involved in 5‑HT2A‑mediated adhesion. Since stimulation of 5-HT2A in 
HEK293 cells results in increased adhesion along with stress fiber formation; the events downstream of 5-HT2A 
stimulation, namely Protein Kinase C (PKC) activation and intracellular  Ca2+ rise, and the signaling molecules 
associated with adhesion and stress fiber formation i.e. PKC and Rho GTPases, were probed.
In  Hu2AAB1 and  Rat2ASB1 cells, PKC activation by 10 nM PMA alone caused an increase in adhesion with 
87 ± 5% (p < 0.001) and 82 ± 5% (p < 0.001) of cells being adherent respectively while in the corresponding vehicle-
treated controls, only 32 ± 8% of  Hu2AAB1 cells and 6 ± 2% of  Rat2ASB1 cells were adherent. HEK293 cells also 
exhibited increased adhesion with 10 nM PMA and 79 ± 16% of treated cells were adherent compared to untreated 
control cells where only 35 ± 11% of the cells were adherent (p < 0.05) (Fig. 5A).
Consistent with this, stimulation of 5-HT2A by serotonin did not lead to increased adhesion in  Hu2AAB1 and 
 Rat2ASB1 cells when activation of PKC, was blocked by light-activated calphostin C. While treatment with 10 μM 
serotonin treatment caused 86 ± 7% of  Hu2AAB1 cells and 86 ± 7% cells of  Rat2ASB1 cells to remain adherent; 
the presence of 500 nM light-activated calphostin C along with serotonin decreased adhesion to 15 ± 3% for 
 Hu2AAB1cells (p < 0.001) and 9 ± 2% for  Rat2ASB1 (p < 0.001) cells (Fig. 5B). HEK293 cells also showed a slight 
decrease in adhesion with 500 nM calphostin C treatment alone with 24 ± 1% of cells adherent compared to 
39 ± 2% of untreated control cells (p < 0.001). Similarly,  Hu2AAB1 cells showed decreased adhesion with calphostin 
C treatment, with 42 ± 17% control cells and only 12 ± 5% of 500 nM calphostin C treated cells staying adherent 
(p < 0.05).  Rat2ASB1 cells on the other hand were poorly adherent to begin with and did not show decreased 
adhesion with calphostin C treatment alone with 7 ± 3% of 500 nM calphostin C treated and 9 ± 2% control cells 
remaining adherent (Supplementary Fig. S4A).
We then examined the role of Rho in serotonin-mediated adhesion of  Hu2AAB1 and  Rat2ASB1 cells. Fol-
lowing a 24 h treatment with 10 μM serotonin using a previously published  protocol20, we found that 96 ± 3% 
of  Hu2AAB1 cells and 97 ± 1% of  Rat2ASB1 cells were adherent; but the same treatment coupled with 10 μM 
CCG-1423, a Rho signaling blocker, resulted in decreased adhesion, with only 33 ± 3% of  Hu2AAB1 (p < 0.001) 
and 47 ± 27% of  Rat2ASB1 (p < 0.05) remaining adherent. In HEK293 cells, treatment with 10 μM CCG-1423 for 
24 h significantly decreased adhesion compared to serotonin-treated control cells also treated for the same time 
period, where only 24 ± 3% of 10 μM CCG-1423 were adherent compared to 37 ± 3% of control cells (p < 0.01) 
(Fig. 5C). From the above results, we conclude that blocking Rho signaling with CCG-1423 had a far greater 
effect on serotonin-mediated adhesion.
Intracellular  Ca2+ plays a species‑specific role in rat and human 5‑HT2A mediated adhesion. To 
analyse if the intracellular  Ca2+ rise that follows 5-HT2A stimulation plays a role in adhesion, a calcium iono-
phore, A23187, was used to increase cytoplasmic  Ca2+. A significant increase in adhesion was seen in the case of 
HEK293 cells and  Hu2AAB1 cells with A23187. Increasing cytoplasmic  Ca2+ with 2 μM A23187 treatment caused 
a substantial increase in adhesion of HEK293 cells with 60 ± 6% of the cells being adherent compared to 29 ± 2% 
of untreated control cells (p < 0.01). Similarly, in  Hu2AAB1 cells, increasing cytoplasmic  Ca2+ with 2 μM A23187 
resulted in a significant increase in adhesion with 49 ± 3% cells adherent compared to 34 ± 2% for control cells 
(p < 0.001); however, in  Rat2ASB1 cells the adhesion was unaffected by 2 μM A23187 and was indistinguishable 
from the control cells with only 12 ± 8% and 13 ± 10% cells remaining adherent respectively (p > 0.05) (Fig. 6A).
As cytoplasmic  Ca2+ rise causes activation of many pathways including calmodulin pathways, W7, a 
pharmacological blocker of calmodulin, was used to probe its involvement. We found that W7 did not affect 
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serotonin-mediated adhesion in  Hu2AAB1 and  Rat2ASB1 cells. While 10 μM serotonin alone caused 105 ± 7% and 
93 ± 10% of cells to adhere respectively in the case of  Hu2AAB1 and  Rat2ASB1 cells, the presence of 10 μM W7 
had negligible effect and 90 ± 8% of  Hu2AAB1 cells and 84 ± 3% of  Rat2ASB1 cells remained adherent. In contrast, 
in HEK293 cells, adhesion was reduced by W7 irrespective of the presence or absence of serotonin (Fig. 6B, 
Supplementary Fig. S4B). We found that a combination of 10 μM W7 and 10 μM serotonin treatment reduced 
cell-adherence to 20 ± 6% compared to cells treated with 10 μM serotonin alone which were 63 ± 12% (p < 0.01) 
adherent (Fig. 6B). In the absence of serotonin only 20 ± 2% of the 10 μM W7 treated HEK293 cells remained 
Figure 4.  Stress fibers are modulated by the activity of 5-HT2A in  Hu2AAB1 cells. (A) Stress fibers appear to be 
absent in untreated control cells (a) and appear on treatment with 10 μM 5-HT (b), they are no longer visible on 
treatment with 10 μM risperidone alone (c) or on treatment with 10 μM risperidone + 10 μM 5-HT (d). Stress 
fibers stained with Phalloidin Alexa 568 are seen as long structures indicated by the arrows. Scale bar represents 
20 µm for all images. (B) The corresponding phase contrast images of cells stained with Phalloidin Alexa 568 
in (A) are shown in (a), (b–d). Scale bar represents 20 µm for all images. (C) The fraction of area occupied by 
stress fibers by the total area occupied by cells with 10 μM 5-HT, 10 μM risperidone and a combination of 10 μM 
risperidone + 10 μM 5-HT treatment compared to untreated control. (D) Cell adhesion profile of  Hu2AAB1 cells 
treated with 10 µM 5-HT in the presence or absence of 10 µM latrunculin A on a fibronectin substrate. Error 
bars represent SD values. The data represented by the gray bars are compared against the respective black bars 
by two tailed students t test; p value less than 0.05 is considered significant. The corresponding p value for the 
asterisks is ***p < 0.001.
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adherent compared to 56 ± 12% of untreated control (p < 0.001) as well (Supplementary Fig. S4B). Interestingly, 
we also observed that  Hu2AAB1and  Rat2ASB1 cells responded differently to W7 alone. In the case of  Hu2AAB1 
cells, there was decrease in adhesion when cells were treated with 10 μM W7 alone and only 20 ± 2% of remained 
adherent compared to 35 ± 6% of untreated control cells (p < 0.05). But in  Rat2ASB1 cells, treatment with W7 
showed no effect on adhesion with 24 ± 1% of 10 μM W7 cells and 24 ± 1% untreated control cells remaining 
adherent (Supplementary Fig. S4B).
Discussion
5-HT2A is a widely studied serotonin receptor, largely owing to its suspected role in neuropsychiatric disorders 
such as schizophrenia and for being a target of antipsychotic drugs and  hallucinogens21–23. In particular many 
antagonists/inverse agonists in schizophrenia for e.g. atypical antipsychotics are believed to act predominantly 
through this  receptor24,25. In our earlier studies, 5-HT2A agonists such as serotonin and DOI, or dopamine—a 
partial agonist were shown to activate the receptor and cause an intracellular  Ca2+ rise in both  Rat2ASB1 and 
 Hu2AAB1  cells11–13,15. We report here that activation of 5-HT2A by these ligands also results in increased adhe-
sion of  Rat2ASB1 and  Hu2AAB1 cells to ‘natural’ substrates such as fibronectin and seems to be mediated through 
integrins. Since untransfected HEK293 cells do not express 5-HT2A13,26, serotonin does not affect the adhesion 
of the parental cell line to these substrates. In the present study, risperidone, olanzapine and chlorpromazine 
were also seen to inhibit 5-HT2A mediated adhesion, and treatment with serotonin, DOI or dopamine increased 
adhesion via activation of the 5-HT2A though they were unable to overcome antagonist-mediated loss of adhesion 
(Supplementary Fig. S5A). Atypical antipsychotics such as  risperidone27 have higher affinities for the 5-HT2A 
receptor than serotonin, DOI or dopamine and can therefore likely to prevent its activation. This could explain 
why antipsychotics were able to cause a decrease in adhesion even in the presence of serotonin and other agonists.
Figure 5.  PKC and Rho GTPase are involved in 5-HT2A-mediated adhesion. (A) Cell adhesion profile of 
HEK293,  Hu2AAB1 and  Rat2ASB1 cells treated with 10 nM PMA compared to untreated controls on fibronectin 
substrate. (B) Cell adhesion profile of HEK293,  Hu2AAB1 and  Rat2ASB1 cells treated with 10 μM 5-HT with 
either no pre-treatment or with pre-treatment with 500 nM light-activated calphostin C on a fibronectin 
substrate. (C) Cell adhesion profile of HEK293,  Hu2AAB1 and  Rat2ASB1 cells after a 24-h treatment with 10 μM 
CCG-1423 + 10 μM 5-HT compared to 10 μM 5-HT treatment alone on a fibronectin substrate. Error bars 
represent SD values. The data represented by the gray bars are compared against the respective black bars by two 
tailed students t test; p value less than 0.05 is considered significant. The corresponding p value for the asterisks 
are *p < 0.05, **P < 0.01, ***p < 0.001, NS p > 0.05.
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In our study we also found that 5-HT2A affected adhesion to natural ECM components such as serum ECM 
adsorbed onto tissue culture plastic or plates pre-coated with fibronectin, but not to poly-d-ornithine, a ‘non-
natural’ substrate. Integrins, the cell adhesion molecules that interact with  fibronectin28–30, were also seen to be 
involved in 5-HT2A-mediated adhesion. In case of poly-d-ornithine which has multiple positively charged amino 
groups, the adhesion observed is not integrin-dependent and is instead based on enhancing electrostatic interac-
tions between the coated surface and the negatively charged residues in the cell  membrane18. This interaction 
seems to override 5-HT2A-mediated adhesion in HEK293-based cell lines.
While we have done our experiments in serum-free media since serum contains serotonin, is known that 
many cells require FBS for attachment, flattening and growth in vitro17. We found that  Hu2AAB1 and  Rat2ASB1 
cells attached strongly in serum-containing media while HEK293 cells always exhibited poor adhesion. As our 
work suggests, the serotonin in the serum can cause such an increase in adhesion in the  Hu2AAB1 and  Rat2ASB1 
cells, while HEK293 cells without the 5-HT2A receptor fail to adhere as strongly. Serum also provides many 
other ECM components or factors for cell attachment and spreading, which might not involve 5-HT2A directly.
We found that in the absence of other pre-coating, the adsorption of ECM components from serum-con-
taining media onto tissue-culture plastic was essential for the cell lines to adhere and we used this for our initial 
experiment. Once the cells adhere to these adsorbed matrices, they flatten and secrete their own ECM compo-
nents over  time31. It must be noted that our cells do not adhere strongly onto TC plastic in the absence of FBS, 
but begin to do so in media supplemented with FBS, as early as 10–15 min. This is consistent with the sequence 
and expected timescale of the events involved in cell-adhesion for e.g. adsorption of ECM components from the 
serum onto to TC plastic to form a substrate onto which cells  attach31,32. In our experiments, we used fibronectin 
as the substrate, because we found adhesion of the cell lines we used to be primarily driven by cell adhesion 
molecules complementary to RGD peptides.
On stimulation, 5-HT2A, like most G-protein coupled receptors (GPCRs), is known to activate several signal-
ing  pathways33, and there are reports that some of the conventionally associated pathways such as PKC are also 
linked with adhesion, e.g. some subtypes of PKC have roles in adhesion and migration in certain cell  types34–36. 
Similarly, the Rho family of small GTPases are known to be associated in actin cytoskeleton dynamics and regu-
late gene-expression associated with adhesion-related  processes37. GPCRs like the 5-HT2A are known to activate 
Rho GTPases—RhoA, Rac and  cdc4237–39. In our study therefore, PKC and Rho GTPases were examined for 
their roles in 5-HT2A-mediated adhesion. We found that they do indeed play significant roles in the 5-HT2A-
mediated adhesion.
Intracellular  Ca2+ signaling, is known to play very important roles in cell adhesion and  flattening40,41. How-
ever, in our study, an increase of intracellular calcium resulted in an increase in adhesion only in  Hu2AAB1 and 
not  Rat2ASB1 cells, which could be due to differences between human and rat receptors, and curiously blocking 
calmodulin did not cause a decrease in adhesion in either cell line.
In the present study, PKC is seen to be indispensable for 5-HT2A-mediated adhesion, which is not surprising 
as it is a part of the canonical 5-HT2A signaling pathway and is commonly associated with adhesion. We see 
increased adhesion with PKC activation and a loss of adhesion on blocking it even in the presence of serotonin, 
emphasizing the central role played by PKC in this process. If PKC is rendered inactive, stimulation of 5-HT2A 
is no longer capable of causing an increase in adhesion. The fact that untransfected HEK293 cells also show an 
increased adhesion with PKC activation and reduced adhesion with PKC inactivation suggests that the molecular 
Figure 6.  Differential involvement of intracellular calcium increase in 5-HT2A mediated adhesion. (A) Cell 
adhesion profile of HEK293,  Hu2AAB1 and  Rat2ASB1 cells treated with 2 μM A23187 treatment compared to 
untreated controls on fibronectin substrate. (B) Cell adhesion profile of HEK293,  Hu2AAB1 and  Rat2ASB1 cells 
treated with 10 µM 5-HT with or without pre-treatment with 10 µM W7 on a fibronectin substrate. Error bars 
represent SD values. The data represented by the gray bars are compared against the respective black bars by two 
tailed students t test; p value less than 0.05 is considered significant. The corresponding p value for the asterisks 
are **p < 0.01, ***p < 0.001, NS p > 0.05.
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players that the 5-HT2A receptor uses for mediating adhesion is also present in HEK293 but stays inactive since 
it cannot be activated by serotonin in the absence of the 5-HT2A receptor.
Rat2ASB1 cells did not show any increase in adhesion with calcium ionophore A23187 treatment, although 
 Hu2AB1and HEK293 cells and cells did show a moderate increase. However, blocking the calmodulin pathways 
by W7 did not result in any loss of 5-HT2A-mediated adhesion. Taken together, the results suggest there are 
significant species-specific differences in the roles for calcium signaling in 5-HT2A mediated adhesion and that 
Calmodulin may not play a role. Therefore, we conclude that, barring species-specific differences, the stimula-
tion of 5-HT2A results has a robust effect on adhesion, with a comparable increase also seen on PKC activation 
by PMA that suggests a key role for PKC. The pathways in play are summarized in Supplementary Fig. S5B.
In Drosophila, knocking out 5-HT2Dro (the fly 5-HT2A ortholog) causes aberrant gastrulation and altered 
sub-cellular localization of adherens junction and lethality in developing  embryos42,43. In mammals, although 
 serotonin44–47 and 5-HT2A48 are expressed early in development, their roles do not seem to be indispensable, 
for e.g. 5-HT2A-deficient mice are viable, fertile and grossly normal, which might be due to compensation by 
the remaining two 5-HT2 receptor subtypes which have similar downstream signaling. However, all ex utero 
cultured mouse embryos treated with atypical antipsychotics, which usually target 5-HT2A among a few other 
receptors, exhibit  malformations48. In addition, mice deficient in serotonin, although seemingly normal at birth, 
show subsequent developmental  delays49–52. This would suggest that serotonin and its receptors like 5-HT2A may 
play a redundant or latent role during development; but extrinsic interventions of receptor functions by means 
of inhibitors/antipsychotics may still prove enormously disruptive. Since differential adhesion is likely to be 
critical during embryo development, malformations seen on antipsychotic treatment could conceivably be due 
to disruption of adhesion.
Although serotonin is widely known as a neurotransmitter, more than 90% of it is found outside the  CNS53,54. 
Similarly, 5-HT2A is also expressed at various non-neuronal sites such as  platelets55, gastrointestinal  tract3, blood 
vessels and vascular smooth muscle  cells56,57, liver and  spleen2,  skin58, bone  cells59,60 and cardiac  fibroblasts61; and 
is attributed pre-nervous system roles as  well48. Thus, 5-HT2A-mediated effects on adhesion can be expected at 
these sites of expression, though direct involvement is yet to be documented. The increased adhesion of HEK293 
cells seen on activation of 5-HT2A and the corresponding decrease seen on 5-HT2A inhibition is exciting.
Besides their role as antipsychotics and antidepressants, many 5-HT2A antagonists have also been widely 
used as anti-thrombogenic  drugs62–64. The effects of antipsychotics are not confined to CNS and they can cause 
side-effects in other tissues, for e.g. eosinophilic  endocarditis65, eosinophilic  pneumonia66,  eosinophilia67,68, bone 
 fragility69 to name a few, and these may be directly or indirectly associated with adhesion-related processes. 
Interestingly, serotonin/SSRIs are even seen to promote metastasis while antipsychotics, have been reported to 
be  remedial70–72.
Our study demonstrates for the first time a novel role for 5-HT2A in cell–matrix adhesion and associated 
cytoskeletal remodelling. Since, 5-HT2A-mediated adhesion extends across multiple systems, from platelets to 
neurons, detailed studies of normal and aberrant cell adhesion in different cell systems may be also useful to 
understand and obviate side-effects associated with antipsychotic medications. It is essential that more stud-
ies are done to explore its significance, particularly in vivo along with a more detailed understanding of the 
mechanisms involved.
Materials and methods
Materials. 5-Hydroxytryptamine/5-HT (Sigma Aldrich, H9523), 2,5-dimethoxy-4-iodoamphetamine/DOI 
(Sigma Aldrich, D101), 3,4-dihydroxyphenethylamine/dopamine or DA (Sigma Aldrich-H8502), chlorproma-
zine (Sigma, 8138), G418 and poly-d-ornithine were purchased from Sigma-Aldrich, USA. Risperidone (Toc-
ris, 2865), olanzapine (Tocris, 4349), phorbol 12-myristate 13-acetate/PMA (Tocris, 1201) and A23187 (Tocris 
52665-69-7) were purchased from Tocris, USA. Calphostin C (Cayman, 121263-19-2), CCG-1423 (Cayman 
285986-88-1), SU6656, W7 (Cayman, 61714-27-0), latrunculin-A (Cayman, 76343-93-6), were purchased from 
Cayman Chemical, USA. Fibronectin, PrestoBlue, Phalloidin Alexa-Fluor 568 were purchased from Invitrogen, 
USA.
Cell culture. HEK293 cell line was obtained from ATCC. Stable lines expressing rat 5-HT2A (SB1 cells) and 
human 5-HT2A (AB1 cells), henceforth to be called  Rat2ASB1 and  Hu2AAB1 cells respectively were from earlier 
 studies13,15. Briefly, HEK293 cells were transfected with a neomycin-resistant plasmid containing either the rat or 
human 5-HT2A by lipofectamine-mediated transfection, and cells stably expressing the receptors were clonally 
expanded and maintained in 1 mg/ml G418. The cells were routinely cultured in 10% DMEM (Invitrogen, USA) 
containing 10% fetal bovine serum (Invitrogen, USA), 50 U/ml penicillin and 50 µg/ml streptomycin (Invitro-
gen, USA) at 37 °C in 5%  CO2.
Cells from confluent T25 flask were harvested by trypsinization, neutralized with 10% DMEM and used for 
experiments. For each cell adhesion experiment around 2 × 105 cells in 10% DMEM (without G418) were seeded 
per well in 24 well dishes (Nunc, USA), either serum ECM, fibronectin or a poly-d-ornithine matrix following 
incubation for 24–36 h, the cell-adhesion assay was performed.
For the cell-adhesion assay, the plate was washed and the adherent cells in each well were serum-starved in 
0.5 ml serum-free DMEM for 45 min at 37 °C and 5%  CO2. Following this, the cells were treated with 5-HT2A 
agonists (serotonin/5-HT, DOI, dopamine), antipsychotics (risperidone/chlorpromazine/olanzapine), PKC 
blocker (calphostin C), PKC activator (PMA), calcium ionophore (A23187), calmodulin blocker (W7), Rho 
signaling blocker (CCG-1423), and stress fiber disruptors (latrunculin A) as needed for 45 min unless otherwise 
mentioned. The solvents for the various compounds were as follows—calphostin C, PMA, W7 and latrunculin A 
were dissolved in ethanol, A23187 and CCG-1423 were dissolved in DMSO and the rest were dissolved in water. 
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The final concentrations of the vehicles in the experimental medium ranged from 0.04% v/v to 0.4% v/v and a 
vehicle control was used in all requisite cases.
Cell-substrate interactions were disrupted by dropping the plates from a fixed height of approximately 5 cm, 
30 times within a metal frame which allowed for controlled disruption. These parameters were determined 
previously based on the conditions required for dislodging the loosely-adherent parent cell-line. Non-adherent 
(floating) cells were then removed by inverting the plate and the remnants of the media were removed with a 
micropipette. The remaining adherent cells were trypsinized and a cell count was done using a haemocytometer 
(direct count) and/or using PrestoBlue dye (Invitrogen, USA) as per manufacturer’s instructions. For each treat-
ment two samples from each well were counted in the case of haemocytometer-based method and three samples 
for PrestoBlue dye-based method. For PrestoBlue dye-based cell counting, 10 μl PrestoBlue dye was added to 
90 μl cell suspension and incubated at 37 °C and 5%  CO2 for 30 min in dark and the fluorescence values were 
used to determine the cell number (Supplementary Fig. S1).
The results were represented as the “Fraction of adherent cells”:
*The total number of cells initially present: while plating cells for adhesion assays, apart from the plate des-
ignated for adhesion assay, in another 24 well plate (identical matrix) at least three wells were loaded with the 
same number of cells and cultured under identical conditions. During the adhesion assay, the average of number 
of cells were determined from these three wells to serve as the most the reliable estimate of average number of 
cells per well (Supplementary Fig. S1).
Each experiment had each treatment in duplicate (as a minimum) and their averages were considered as one 
data point. Each experiment was repeated thrice for biological replicates.
Cell attachment assay with an integrin blocker. Hu2AAB1 cells and HEK293 cells were harvested 
using an enzyme free cell dissociation buffer (Sigma, USA), re-suspended in DMEM containing dialyzed serum 
(which is serotonin-free) supplemented with 10 μM serotonin, and the cell suspension was diluted to 1.5 × 105 
cells/ml. Then 20 μM RGD peptide was added to the suspension and incubated at 37 °C and 5%  CO2 for 60 min. 
Following the incubation, 6 × 104 cells were plated onto fibronectin pre-coated (0.1 μg/ml, 60 min at 37 °C) wells 
of a 24-well dish and allowed to attach for 60 min. Finally, the media along with the unattached cells were aspi-
rated and the attached cells were counted using PrestoBlue (Invitrogen, USA).
Phalloidin staining. 4 × 104 cells were plated on 15 mm-diameter coverslip dishes pre-coated with 0.1 µg/
ml fibronectin and incubated for 24–36 h for the cells to attach and spread. The dishes were washed and serum-
starved in plain DMEM for 45 min. The cells were then treated with 10 µM serotonin and risperidone for 45 min. 
Following the treatment, the dishes were washed in phosphate buffered saline (PBS) and fixed with 4% PFA in 
PBS for 20 min. After fixation, the dishes were washed twice with PBS and permeabilized with 0.1% Triton for 
five minutes. After a further two washes with PBS, the cells were incubated with 5% BSA for 30 min to block 
non-specific binding, washed with PBS and stained with 50 nM Phalloidin Alexa 568 (Invitrogen, USA) in 1% 
BSA for 60 min. The dishes were washed twice in PBS, DABCO was added and the cells were imaged with an 
epifluorescence microscope.
Image acquisition. Nikon Eclipse T2000E-PFS (Japan) attached to a Photometrix Cascade II 512 EM-CCD 
camera (Roper Scientific, USA) controlled by Image Pro-Plus AMS software (Media Cybernetics, USA). A 60X/
NA 1.4 oil immersion objective was used. Phalloidin Alexa-Fluor 568 fluorescence was visualized through a fil-
ter procured from Chroma Technologies (Rockingham, USA): Exciter 545 nm/30, dichroic 620 nm/60, Emitter 
575 nm long pass.
Quantification of area under stress fibers. The total area under stress fiber was calculated as the cumu-
lative area of all pixels above a threshold intensity in phalloidin-stained images using FIJI/ImageJ. Since the 
fluorophore only stained actin fibres and non-specific staining was very limited, the threshold was defined using 
controls that were not treated by ligand. Since the stress fibers had higher intensity than the background or non-
specific signals arising from other structures in the image the thresholding selected only the area occupied by 
stress fibers. The ratio of total area occupied by stress fibers to the total area occupied by the cells in that image 
was compared between the samples. The analysis consisted of ten images from each treatment. The images were 
all captured under identical condition, illumination, duration and gain.
Data presentation. Some of the data was collected as a part of large, multi-parameter experiments. For 
the sake of clarity we have presented the results are separately in context of the substrate/drug being discussed 
in order to aid the comprehension of results. Due to this, some of the shared controls appear to be repeated in 
different figures. The details are as follows:
The data for serotonin treatment of HEK293,  Hu2AAB1 and  Rat2ASB1 on serum ECM in Fig. 1A is also 
presented in Fig. 3A. The data for serotonin treatment of  Hu2AAB1 and  Rat2ASB1 on fibronectin substrate in 
Fig. 1B is also presented in Fig. 5B. The data for DOI and DA treatment of  Hu2AAB1 on fibronectin substrate in 
Fig. 1C (which shows absence and presence of DOI/DA) is also presented in Fig. 3D (which looks at DOI/DA 
in the absence/presence of risperidone). The data for serotonin treatment of  Hu2AAB1 and  Rat2ASB1 on poly-
d-ornithine substrate in Fig. 2A is also presented in Fig. 3C (where it is compared with risperidone treatment on 
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poly-d-ornithine substrate). The data for serotonin treatment of  Hu2AAB1 and  Rat2ASB1 in fibronectin substrate 
in Fig. 3C (as a control for risperidone treatment) is also presented in Fig. 3E (as a control for olanzapine and 
chlorpromazine treatment) and Fig. 6B (W7 treatment control). The data for untreated control of  Hu2AAB1 
and  Rat2ASB1 in fibronectin substrate in Fig. 1B is also presented in Supplementary Fig. S4A (as a control for 
calphostin C treatment).
Statistical analysis. Data are expressed as mean ± standard deviation of the mean. The data was analysed 
by two tailed Student’s t test. Statistical significance was determined as p < 0.05.
Lilliefors goodness-of-fit test of composite normality was used to check the normality of each dataset in the 
case of compilation of data from the entire duration of the study. The datasets with a resultant critical value 
(LCRIT) values below the critical value based on the Lilliefors test table with alpha value of 0.05 is considered 
as a normal distribution.
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